NCT01863459View on ClinicalTrials.gov

Lisdexamfetamine Dimesylate in the Treatment of Adult ADHD With Anxiety Disorder Comorbidity

PHASE4CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions
Adult Attention Deficit Hyperactivity Disorder (ADHD) With Co-occuring Anxiety and Depressive Disorders
Interventions
DRUG

Lisdexamfetamine Dimesylate

DRUG

placebo

Trial Locations (1)

L8S 1B7

Centre for Anxiety, Attention Deficit and Trauma, Hamilton

Sponsors

Collaborators (1)

Shire
All Listed Sponsors
collaborator

Shire

INDUSTRY

lead

Centre for Anxiety, Attention Deficit and Trauma, Ontario, Canada

OTHER